In July 2025, the federal government is introducing a National Lung Cancer Screening Program (NLCSP) targeting the population most at risk, aiming for early detection of lung cancer.
ELUCiD has positioned itself at the forefront of the clinical response to this program with the implementation of a comprehensive lung cancer screening service incorporating its existing services together with an expanding array of:
- CNC lead Rapid triage of referrals
- Clinics
- World-leading diagnostic procedures
- GP support services
- Multidisciplinary team discussions
- Comprehensive treatment options
Company Details
- Employees
- 2
- Founded
- -
- Address
- Technology Pl, 203,australia
- Industry
- Medical Practices
- NAICS
-
Ambulatory Health Care ServicesOffices of Other Health PractitionersOutpatient Care CentersOther Ambulatory Health Care ServicesOffices of All Other Health PractitionersOutpatient Mental Health and Substance Abuse CentersAll Other Ambulatory Health Care ServicesOffices of PodiatristsBlood and Organ BanksAll Other Miscellaneous Ambulatory Health Care Services
- Keywords
- Interventional Pulmonology, Thoracic Surgery, Radiology, Thoracic Medicine, Medical Oncology, Radiation Oncology.
- HQ
- Macquarie Park, New South Wales
- Competitors
- Adelaide Interventional Pulmonology and Pleural Group, Sydney Interventional Pulmonology and Innovations Centre (SIPIC), Royal Prince Alfred Hospital, Lung Foundation Australia, MQ Health Interventional Pulmonology, Benchmark Sleep Services, Longziekten en Tuberculose UMCG, AstraZeneca, Concord Repatriation General Hospital, RPA Institute for Academic Medicine.
Early Lung Cancer Detection Program (Elucid) Questions
Early Lung Cancer Detection Program (Elucid)'s website is https://www.mqhealth.org.au/services/find-a-service/respiratory-and-sleep-clinic/our-specialist-services/early-lung-cancer-detection-elucid-program
Early Lung Cancer Detection Program (Elucid)'s LinkedIn profile is https://au.linkedin.com/company/early-lung-cancer-detection-program-elucid
Early Lung Cancer Detection Program (Elucid) has
2 employees.
View email and phone details for 2
employees at Early Lung Cancer Detection Program (Elucid).
Early Lung Cancer Detection Program (Elucid)'s industry is
Medical Practices
Early Lung Cancer Detection Program (Elucid)'s top competitors are
Adelaide Interventional Pulmonology And Pleural Group,
Sydney Interventional Pulmonology And Innovations Centre (Sipic),
Royal Prince Alfred Hospital,
Lung Foundation Australia,
Mq Health Interventional Pulmonology,
Benchmark Sleep Services,
Longziekten En Tuberculose Umcg,
Astrazeneca,
Concord Repatriation General Hospital,
Rpa Institute For Academic Medicine.
Early Lung Cancer Detection Program (Elucid)'s categories are Medical Practices
Early Lung Cancer Detection Program (Elucid)'s founding year is 2024
